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Obesity in Children and Future
Cardiometabolic Risk
Are blood tests necessary?
R
ates of pediatric obesity have in-
creasedsubstantiallyinrecentyears
(1) and now pose a major risk for
increased morbidity and premature mor-
talityinadulthoodforthoseaffected,with
cardiovascular disease (CVD) being a ma-
jor contributor. In the current issue, Lib-
man et al. (2) examine the relationship
between glucose and insulin in over-
weight children and adolescents and a
range of biomarkers for cardiovascular
disease.Theyreportthatincreasedfasting
and postprandial insulin are related to
CVDriskfactors,includingsystolicblood
pressure and triglycerides, whereas glu-
cose is not.
These results are perhaps not surpris-
ing given what we already know about
glucose homeostasis in obese children
and adolescents (3) and recent evidence
supporting a relatively weak relationship
between elevations in fasting glucose
within the normal range and incident
CVD events in adults (4). Hyperinsulin-
emia is the hallmark of metabolic dys-
function in children and adolescents,
with hyperglycemia not manifesting until
a very late stage of -cell failure (3), mak-
ingtheprocessfarlengthierthaninadults
and reﬂecting the ability of the young
pancreas to better compensate.
Given the epidemic of childhood and
adolescent obesity, there is an urgent
need for a strong evidence base to help
guide clinicians and other health profes-
sionsintheirassessmentandtreatmentof
children with these conditions. In this re-
gard, Libman et al. conclude that “there is
a need to determine the best marker for
early identiﬁcation of CVD morbidity in
this population.” But is their suggested
approach reasonable? Oral glucose toler-
ance tests including insulin are time-
consuming and costly, and they involve a
clinic visit and venepuncture which is
stressful for children. Are there clear clin-
ical advantages to this complicated,
stressfultestoversimplemeasuressuchas
body mass? The authors do not report the
associations between body mass or per-
centage fat mass and cardiovascular risk
factors, though power may be limited in
their small, heterogeneous sample con-
sisting of several ethnicities and a wide
agerangethatspanspuberty.Fortunately,
such data already exist from several
sources, with a number of studies (5–8)
showing a strong relationship between
children’s body mass and cardiovascular
risk markers, carotid intima-media thick-
ness, and adult heart mass. Perhaps more
importantly, new prospective data from
the Avon Longitudinal Study of Parents
andChildren(ALSPAC)reportsstrongre-
lationships between several measures of
adiposity at age 9 years and subsequent
CVD risk markers at age 15 years, with
BMI being equally as good an indicator as
fat mass and waist circumference (9).
These latter data, in turn, concur with ep-
idemiological evidence linking adiposity
in childhood with CVD risk in later
life (10).
An early marker of insulin resis-
tance might be useful if there was a spe-
ciﬁc targeted treatment option that
improvedoutcomesintheseindividuals
above others. Currently, no such treat-
ment exists, though there may be temp-
tation to use medications such as
metformin or even statins in this popu-
lation. Caution should be heeded: until
these treatments are fully investigated
in prospective, randomized trials there
can be little justiﬁcation for their use.
Would such treatments be life-long? Al-
though some evidence exists on the
short-term relative safety of statin ther-
apy in children (11) the unknowns of
using metformin and statins are not
only the effect on future cardiovascular
outcomes, but also the effect in such a
young cohort on future pregnancies,
long-termgrowth,orincreaseddiabetes
risk associated with using statins (12),
not forgetting the potential psychological
and societal consequences of burdening
children with a medical diagnosis for
what is only a potential future risk.
Quality of life has to be considered at all
times.
Ofcourse,whatisactuallyrequiredis
weight loss or weight maintenance in
growing children. Childhood obesity is
not only likely to increase the future
risk of CVD and diabetes, but also that
of cancers, liver disease, osteoarthritis,
depression,andanxiety—withhugeim-
plications for not only the individual but
also for society through lost days of
work and increased health costs. The
point here is that all overweight and
obese children, not just those at the
highest risk for CVD or diabetes, need
healthy weight interventions because
weight loss will treat all potential risks,
not only CVD or diabetes. Nevertheless,
itwasreassuringtonotethatchildrenin
ALSPAC who favorably altered their
overweight status between childhood
and adolescence improved their cardio-
vascular risk proﬁle (9).
Weight loss interventions in any age-
groupareneithersimplenorinexpensive.
Best evidence suggests they need to be
multicomponent, fully involving the
whole family, and supported by schools
and the community (13). There is some
evidencefortheuseofbariatricsurgeryin
severely obese adolescents (14) but no
data as to the long term consequences of
such action. There is an urgent need for
the efforts against childhood obesity to
increaseseveral-fold;preventionoffuture
obesityisparamount,andgovernmentin-
tervention in the food industry is the
linchpin of this. For those already af-
fected, evidence-based weight manage-
ment programs that result in global risk
reduction are required. There may be a
case for more targeted cardiovascular risk
reduction in the future, but we must not
forget that because energy imbalance is
causal, it should be the primary focus of
our efforts.
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